TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Vivian Lindo
Associate Director, Analytical Sciences at AstraZeneca

Profile

Dr Viv Lindo has spent over 20 years in the field of protein characterisation. He completed a PhD at Kings College London (1991-1994) and after a successful Post Doc at Imperial College London, working in the Physical Biochemistry group lead by Professor Howard Morris, he went on to work at SGS M-Scan (formerly M-Scan) applying, amongst other techniques, mass spectrometry-based structural methods to the characterisation of biomolecules. Joining MedImmune/AstraZeneca in January 2011, he leads the Physicochemical Development group within Analytical Sciences managing a strong team of scientists dedicated to applying state-of-the-art analytical technologies (including mass spectrometry) to gain a greater understanding of the biophysical and biochemical nature of peptides and proteins in development.

Vivian Lindo's Network

Agenda Sessions

  • Workshop Moderator’s Opening Remarks

    , 08:00
  • Probing Protein Higher Order Structure with Mass Spectrometry

    , 08:15